CEFMENOXIME HEMIHYDROCHLORIDE

CEFMENOXIME HEMIHYDROCHLORIDE

(6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxylamido)-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid 7(2)-(Z)-(O-methyloxime) hydrochloride (2:1); Cefmenoxime hydrochloride; Cefmax; Bestcall; CMX; (6R,7R)-7-((2-(2-amino-1,3-thiazol-4-yl)-2-methoxyimino-acetyl)amino)-3-((1-methyltetrazol-5-yl)sulfanylmethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid hydrochloride; (6R-(6alpha,7beta(Z)))-7-(((2-Amino-4-thiazolyl)(methoxyimino)acetyl)amino)-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid Hemihydrochloride;

CAS RN	:	75738-58-8
EINECS RN	:	278-299-4
FORMULA	:	C₁₆H₁₈ClN₉O₅
MASS	:	528.79
DESCRIPTION	:	A 3rd generation cephalosporin stable to hydrolysis by beta-lactamases; administered intravenously or intramuscularly. Effective against most common gram-positive and gram-negative organisms; resistant to hydrolysis by beta-lactamases and potent inhibitor of enterobacteriaceae. Structurally related to cefotaxime and ceftizoxime; similar activity and use to cefotaxime sodium.